Details of the Drug Reposition

General Information of This Drug (ID: DMJTU8D)

Drug Name
OGX-427   DMJTU8D
Therapeutic Class
Antisense
Drug Type
Antisense drug
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
5 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Lung cancer DISCM4YA 2C25.0 Phase 2 [1]
Breast cancer DIS7DPX1 2C60-2C65 Phase 2 [1]
Ovarian cancer DISZJHAP 2C73 Phase 2 [1]
Prostate cancer DISF190Y 2C82.0 Phase 2 [1]
Bladder cancer DISUHNM0 2C94 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02423590) Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers. U.S. National Institutes of Health.